{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T20:57:24Z","timestamp":1790542644613,"version":"4.1.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,21]],"date-time":"2024-06-21T00:00:00Z","timestamp":1718928000000},"content-version":"vor","delay-in-days":20,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["IF180797"],"award-info":[{"award-number":["IF180797"]}],"id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.heliyon.2024.e33505","type":"journal-article","created":{"date-parts":[[2024,6,22]],"date-time":"2024-06-22T03:06:38Z","timestamp":1719025598000},"page":"e33505","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Exploring the therapeutic potential of silymarin-based herbal remedy (prebiotic) and probiotic blend in a mouse model of NAFLD: Insights into gut microbiota modulation and liver health"],"prefix":"10.1016","volume":"10","author":[{"given":"Tanya","family":"Ralli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahnawaz","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoya","family":"Saifi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulsalam","family":"Alhalmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vidhu","family":"Aeri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohd","family":"Aqil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanchan","family":"Kohli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.heliyon.2024.e33505_bib1","article-title":"Relative recovery of non-alcoholic fatty liver disease (NAFLD) in diet-induced obese rats","volume":"16","author":"Aboujassoum","year":"2024","journal-title":"Nutrients"},{"key":"10.1016\/j.heliyon.2024.e33505_bib2","doi-asserted-by":"crossref","first-page":"4677","DOI":"10.2174\/1389201022666210625141526","article-title":"Gut microbiota as an emerging therapeutic avenue for the treatment of nonalcoholic fatty liver disease","volume":"27","author":"Ralli","year":"2021","journal-title":"Curr. Pharmaceut. Des."},{"key":"10.1016\/j.heliyon.2024.e33505_bib3","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1016\/j.jhep.2014.12.012","article-title":"NAFLD: a multisystem disease","volume":"62","author":"Byrne","year":"2015","journal-title":"J. Hepatol."},{"key":"10.1016\/j.heliyon.2024.e33505_bib4","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1007\/s10620-016-4079-4","article-title":"Fibrosis assessment in nonalcoholic fatty liver disease (NAFLD) in 2016","volume":"61","author":"Kaswala","year":"2016","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.heliyon.2024.e33505_bib5","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1002\/hep.28123","article-title":"Association of nonalcoholic fatty liver disease (NAFLD) with hepatocellular carcinoma (HCC) in the United States from 2004 to 2009","volume":"62","author":"Younossi","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.heliyon.2024.e33505_bib6","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1365-2036.2011.04724.x","article-title":"Systematic review: the epidemiology and natural history of non\u2010alcoholic fatty liver disease and non\u2010alcoholic steatohepatitis in adults","volume":"34","author":"Vernon","year":"2011","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.heliyon.2024.e33505_bib7","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nrgastro.2013.41","article-title":"Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis","volume":"10","author":"Anstee","year":"2013","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.heliyon.2024.e33505_bib8","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/nrneph.2017.16","article-title":"Non-alcoholic fatty liver disease: an emerging driving force in chronic kidney disease","volume":"13","author":"Targher","year":"2017","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.heliyon.2024.e33505_bib9","doi-asserted-by":"crossref","DOI":"10.3390\/fermentation10030116","article-title":"Enhanced anti-inflammatory and non-alcoholic fatty liver disease (NAFLD) improvement effects of Bacillus subtilis-fermented fagopyrum tataricum gaertner","volume":"10","author":"Park","year":"2024","journal-title":"Fermentation"},{"key":"10.1016\/j.heliyon.2024.e33505_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.jff.2023.105819","article-title":"Effects of Eucommia ulmoides Oliver leaves on gut microbiota and intestinal function during in vitro simulated digestion and fermentation","volume":"109","author":"Wang","year":"2023","journal-title":"J. Funct.Foods"},{"key":"10.1016\/j.heliyon.2024.e33505_bib11","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1080\/1040841X.2022.2142091","article-title":"Deciphering the role of gut metabolites in non-alcoholic fatty liver disease","volume":"49","author":"Ralli","year":"2023","journal-title":"Crit. Rev. Microbiol."},{"key":"10.1016\/j.heliyon.2024.e33505_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2022.908011","article-title":"The role of gut microbiota-bile acids Axis in the progression of non-alcoholic fatty liver disease","volume":"13","author":"Ni","year":"2022","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.heliyon.2024.e33505_bib13","first-page":"444","article-title":"Gut microbiome and nonalcoholic fatty liver disease, Hepatobiliary Pancreat","volume":"22","author":"Wu","year":"2023","journal-title":"Dis. Int."},{"key":"10.1016\/j.heliyon.2024.e33505_bib14","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines12030515","article-title":"Updated insights into probiotics and hepatobiliary diseases","volume":"12","author":"Xu","year":"2024","journal-title":"Biomedicines"},{"key":"10.1016\/j.heliyon.2024.e33505_bib15","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1002\/hep4.1331","article-title":"Role of the gut-liver Axis in liver inflammation, fibrosis, and cancer: a special focus on the gut microbiota relationship","volume":"3","author":"Ohtani","year":"2019","journal-title":"Hepatol. Commun."},{"key":"10.1016\/j.heliyon.2024.e33505_bib16","article-title":"Gut microbiota metabolites in NAFLD pathogenesis and therapeutic implications","volume":"21","author":"Chen","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.heliyon.2024.e33505_bib17","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.jff.2017.11.024","article-title":"Hepatoprotective effect of esculetin on ethanol-induced liver injury in human HepG2 cells and C57BL\/6J mice","volume":"40","author":"Lee","year":"2018","journal-title":"J. Funct.Foods"},{"key":"10.1016\/j.heliyon.2024.e33505_bib18","first-page":"104","article-title":"Clinical and regulatory status of silymarin","volume":"8","author":"Ralli","year":"2021","journal-title":"Appl. Drug Res. Clin. Trials Regul. Aff."},{"key":"10.1016\/j.heliyon.2024.e33505_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.jff.2023.105671","article-title":"Novel Nutraceutical (silymarin, yeast \u03b2-glucan, prebiotics, and minerals) shifts gut microbiota and restores large intestine histology of diet-induced metabolic syndrome mice","volume":"107","author":"Nehmi-Filho","year":"2023","journal-title":"J. Funct.Foods"},{"key":"10.1016\/j.heliyon.2024.e33505_bib20","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s43088-022-00196-1","article-title":"Molecular and pharmacological aspects of piperine as a potential molecule for disease prevention and management: evidence from clinical trials","volume":"11","author":"Tripathi","year":"2022","journal-title":"Beni-Suef Univ. J. Basic Appl. Sci."},{"key":"10.1016\/j.heliyon.2024.e33505_bib21","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1038\/s41598-024-51726-z","article-title":"The impact of piperine on the metabolic conditions of patients with NAFLD and early cirrhosis: a randomized double-blind controlled trial","volume":"14","author":"Nouri-Vaskeh","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.heliyon.2024.e33505_bib22","article-title":"The effect of curcumin with piperine supplementation on pro-oxidant and antioxidant balance in patients with non-alcoholic fatty liver disease: a randomized, double-blind, placebo-controlled trial, Drug Metab","volume":"34","author":"Mirhafez","year":"2019","journal-title":"Pers. Ther."},{"key":"10.1016\/j.heliyon.2024.e33505_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.jff.2020.104011","article-title":"Effects of piperine on lipid metabolism in high-fat diet induced obese mice","volume":"71","author":"Du","year":"2020","journal-title":"J. Funct.Foods"},{"key":"10.1016\/j.heliyon.2024.e33505_bib24","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/5391014","article-title":"Therapeutic potential of fulvic acid in chronic inflammatory diseases and diabetes","volume":"2018","author":"Winkler","year":"2018","journal-title":"J. Diabetes Res."},{"key":"10.1016\/j.heliyon.2024.e33505_bib25","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.rvsc.2022.07.001","article-title":"Effects of humic acid and organic acids supplements on performance, meat quality, leukocyte count, and histopathological changes in spleen and liver of broiler chickens","volume":"150","author":"Akaichi","year":"2022","journal-title":"Res. Vet. Sci."},{"key":"10.1016\/j.heliyon.2024.e33505_bib26","article-title":"Fulvic acids-like substances exuded from shiitake mushroom beds\u2014amount, chemical characteristics, and antioxidant capacity","volume":"25","author":"Watanabe","year":"2024","journal-title":"Bioresour. Technol. Rep."},{"key":"10.1016\/j.heliyon.2024.e33505_bib27","article-title":"Effects of fulvic acid on broiler performance, blood biochemistry, and intestinal microflora","volume":"103","author":"Liu","year":"2024","journal-title":"Poultry Sci."},{"key":"10.1016\/j.heliyon.2024.e33505_bib28","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/8846401","article-title":"Novel organic mineral complex prevents high-fat diet-induced changes in the gut and liver of male sprague-dawley rats","volume":"2020","author":"Crawford","year":"2020","journal-title":"J. Nutr. Metab"},{"key":"10.1016\/j.heliyon.2024.e33505_bib29","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.molmet.2019.08.020","article-title":"Fibroblast growth factor 21 is required for the therapeutic effects of Lactobacillus rhamnosus GG against fructose-induced fatty liver in mice","volume":"29","author":"Zhao","year":"2019","journal-title":"Mol. Metabol."},{"key":"10.1016\/j.heliyon.2024.e33505_bib30","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1021\/pr501121c","article-title":"Hepatic and fecal metabolomic analysis of the effects of lactobacillus rhamnosus GG on alcoholic fatty liver disease in mice","volume":"14","author":"Shi","year":"2015","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.heliyon.2024.e33505_bib31","doi-asserted-by":"crossref","DOI":"10.3390\/antiox12030717","article-title":"Beneficial effects of viable and heat-inactivated lactobacillus rhamnosus GG administration on oxidative stress and inflammation in diet-induced NAFLD in rats","volume":"12","author":"Arellano-Garc\u00eda","year":"2023","journal-title":"Antioxidants"},{"key":"10.1016\/j.heliyon.2024.e33505_bib32","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.jnutbio.2014.10.016","article-title":"Enhanced AMPK phosphorylation contributes to the beneficial effects of Lactobacillus rhamnosus GG supernatant on chronic-alcohol-induced fatty liver disease","volume":"26","author":"Zhang","year":"2015","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.heliyon.2024.e33505_bib33","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11020640","article-title":"The effects of probiotics on small intestinal microbiota composition, inflammatory cytokines and intestinal permeability in patients with non-alcoholic fatty liver disease","volume":"11","author":"Ayob","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.heliyon.2024.e33505_bib34","doi-asserted-by":"crossref","first-page":"6115","DOI":"10.1039\/C9FO02905B","article-title":"Bifidobacterium adolescentis and Lactobacillus rhamnosus alleviate non-alcoholic fatty liver disease induced by a high-fat, high-cholesterol diet through modulation of different gut microbiota-dependent pathways","volume":"11","author":"Wang","year":"2020","journal-title":"Food Funct."},{"key":"10.1016\/j.heliyon.2024.e33505_bib35","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms7110561","article-title":"Gut bacteria and their metabolites: which one is the defendant for colorectal cancer?","volume":"7","author":"Tarashi","year":"2019","journal-title":"Microorganisms"},{"key":"10.1016\/j.heliyon.2024.e33505_bib36","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1210\/en.2009-0869","article-title":"Spironolactone improves glucose and lipid metabolism by ameliorating hepatic steatosis and inflammation and suppressing enhanced gluconeogenesis induced by high-fat and high-fructose diet","volume":"151","author":"Wada","year":"2010","journal-title":"Endocrinology"},{"key":"10.1016\/j.heliyon.2024.e33505_bib37","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1080\/10837450.2023.2227966","article-title":"In-silico, in-vitro and ex-vivo evidence of combining silymarin phytopharmaceutical with piperine, and fulvic acid for enhancing its solubility and permeability","volume":"28","author":"Ralli","year":"2023","journal-title":"Pharmaceut. Dev. Technol."},{"key":"10.1016\/j.heliyon.2024.e33505_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.cjac.2022.100174","article-title":"Silymarin as a phyto-pharmaceutical: isolation, simultaneous quantification of four biomarkers and in-silico anti-inflammatory activity","volume":"51","author":"Ralli","year":"2023","journal-title":"Chin. J. Anal. Chem."},{"key":"10.1016\/j.heliyon.2024.e33505_bib39","doi-asserted-by":"crossref","DOI":"10.3390\/nu11123067","article-title":"Nonalcoholic fatty liver disease induced by high-fat diet in C57bl\/6 models","volume":"11","author":"Recena Aydos","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/j.heliyon.2024.e33505_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2023.104779","article-title":"Pharmacological inhibition of DNMT1 restores macrophage autophagy and M2 polarization in Western diet-induced nonalcoholic fatty liver disease","volume":"299","author":"Pant","year":"2023","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.heliyon.2024.e33505_bib41","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.phrs.2005.05.004","article-title":"Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: a model for type 2 diabetes and pharmacological screening","volume":"52","author":"Srinivasan","year":"2005","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.heliyon.2024.e33505_bib42","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1358\/mf.2004.26.5.831322","article-title":"Reversal of glucose intolerance by by pioglitazone in high fat diet-fed rats","volume":"26","author":"Srinivasan","year":"2004","journal-title":"Methods Find. Exp. Clin. Pharmacol."},{"key":"10.1016\/j.heliyon.2024.e33505_bib43","doi-asserted-by":"crossref","DOI":"10.3390\/nu11112586","article-title":"Efficacy and mechanism of polymerized anthocyanin from grape-skin extract on high-fat-diet-induced nonalcoholic fatty liver disease","volume":"11","author":"Fan","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/j.heliyon.2024.e33505_bib44","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1038\/s41374-018-0074-z","article-title":"Characterization of a murine nonalcoholic steatohepatitis model induced by high fat high calorie diet plus fructose and glucose in drinking water","volume":"98","author":"Liu","year":"2018","journal-title":"Lab. Invest."},{"key":"10.1016\/j.heliyon.2024.e33505_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.sintl.2020.100003","article-title":"Carbon nanotube - a review on synthesis , properties and plethora of applications in the field of biomedical science","volume":"1","author":"Anzar","year":"2020","journal-title":"Sensors Int"},{"key":"10.1016\/j.heliyon.2024.e33505_bib46","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2022.1051200","article-title":"Characteristics of intestinal microbiota in C57BL\/6 mice with non-alcoholic fatty liver induced by high-fat diet","volume":"13","author":"Yan","year":"2022","journal-title":"Front. Microbiol."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024095367?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024095367?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T20:38:36Z","timestamp":1790541516000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844024095367"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":46,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S2405844024095367"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e33505","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploring the therapeutic potential of silymarin-based herbal remedy (prebiotic) and probiotic blend in a mouse model of NAFLD: Insights into gut microbiota modulation and liver health","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e33505","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e33505"}}